GENZYME CORP Capital Expenditures
GENZYME CORP reported Capital Expenditures of $654.11 million for the 12-month period ending 2010-12-31, per its 10-K filed 2011-03-01.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2011-03-01
- GENZYME CORP payments to acquire property, plant, and equipment for the quarter ending 2010-12-31 was $156.17M, a 13.85% decline year-over-year.
- GENZYME CORP payments to acquire property, plant, and equipment for the quarter ending 2010-09-30 was $167.63M, a 3.41% increase year-over-year.
- GENZYME CORP payments to acquire property, plant, and equipment for the quarter ending 2010-06-30 was $178.08M, a 13.60% increase year-over-year.
- GENZYME CORP payments to acquire property, plant, and equipment for the quarter ending 2010-03-31 was $152.22M, a 5.78% decline year-over-year.
- GENZYME CORP payments to acquire property, plant, and equipment for fiscal 2010 was $654.11M, a 1.15% decline from fiscal 2009.
- GENZYME CORP payments to acquire property, plant, and equipment for fiscal 2009 was $661.71M, a 10.74% increase from fiscal 2008.
- GENZYME CORP payments to acquire property, plant, and equipment for fiscal 2008 was $597.56M.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2010-12-31 | $156.17M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $323.81M derived: sum of 2 quarters · filed 2011-03-01 | $501.88M derived: sum of 3 quarters · filed 2011-03-01 | $654.11M 10-K · filed 2011-03-01 |
| 2010-09-30 | $167.63M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-11-09 | $345.71M derived: sum of 2 quarters · filed 2010-11-09 | $497.93M 10-Q · filed 2010-11-09 | $679.21M derived: sum of 4 quarters · filed 2011-03-01 |
| 2010-06-30 | $178.08M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2010-09-07 | $330.30M 10-Q/A · filed 2010-09-07 | $511.57M derived: sum of 3 quarters · filed 2011-03-01 | $673.69M derived: sum of 4 quarters · filed 2011-03-01 |
| 2010-03-31 | $152.22M 10-Q/A · filed 2010-05-11 | $333.50M derived: sum of 2 quarters · filed 2011-03-01 | $495.61M derived: sum of 3 quarters · filed 2011-03-01 | $652.37M derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-12-31 | $181.28M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $343.39M derived: sum of 2 quarters · filed 2011-03-01 | $500.15M derived: sum of 3 quarters · filed 2011-03-01 | $661.71M 10-K · filed 2011-03-01 |
| 2009-09-30 | $162.11M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-11-09 | $318.88M derived: sum of 2 quarters · filed 2010-11-09 | $480.44M 10-Q · filed 2010-11-09 | $644.01M derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-06-30 | $156.76M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2010-09-07 | $318.32M 10-Q/A · filed 2010-09-07 | $481.90M derived: sum of 3 quarters · filed 2011-03-01 | $664.10M derived: sum of 4 quarters · filed 2011-03-01 |
| 2009-03-31 | $161.56M 10-Q/A · filed 2010-05-11 | $325.14M derived: sum of 2 quarters · filed 2011-03-01 | $507.34M derived: sum of 3 quarters · filed 2011-03-01 | |
| 2008-12-31 | $163.57M derived: 10-K 12 month − 10-Q 9 month · filed 2011-03-01 | $345.78M derived: sum of 2 quarters · filed 2011-03-01 | $597.56M 10-K · filed 2011-03-01 | |
| 2008-09-30 | $182.20M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2009-11-02 | $433.99M 10-Q · filed 2009-11-02 | ||
| 2008-06-30 | $251.78M 10-Q/A · filed 2009-09-04 | |||
| 2007-12-31 | $412.87M 8-K · filed 2010-06-14 |